Paperonium

← Back to the plain-language case

Abstract's risk-factor-adjusted hazard ratios for three fat measures match a BMI-adjusted supplementary model, not Table 2

BMC Med (2022) Β· doi:10.1186/s12916-022-02505-y Β· PMC9484252

Summary

The abstract says that "after adjustments for cardiovascular risk factors", total fat mass, gynoid fat mass and the android-to-gynoid fat ratio had hazard ratios for new-onset atrial fibrillation (AF) of 1.33 (1.05–1.68), 1.36 (1.12–1.65) and 0.81 (0.70–0.94). Table 2 (Model 2) and the Results text describe the same adjustment, and both give 1.22 (1.09–1.36), 1.26 (1.13–1.41) and 0.85 (0.74–0.98). The three abstract values match exactly, to every printed digit, the Model 2 column of Supplementary Table S6, which adds body mass index (BMI) to the cardiovascular-risk-factor model. The fourth estimate in the same abstract sentence, epicardial fat at 1.27 (1.09–1.48), comes from the model without BMI. So the abstract labels two different models with one description. As a result it overstates the risk-factor-adjusted hazard ratios for total and gynoid fat by about 8–9% and gives intervals 1.75 to 2.1 times wider than the model it names. No direction or significance changes, and the paper's lean-mass-adjusted results and its conclusions are not affected.

What the paper reports

Abstract, Results, second sentence:

After adjustments for cardiovascular risk factors, absolute fat mass (HR; 95% CI 1.33; 1.05–1.68), gynoid fat mass (HR; 95% CI 1.36; 1.12–1.65), epicardial fat mass (HR; 95% CI 1.27; 1.09-1.48), and android-to-gynoid fat ratio (HR; 95% CI 0.81; 0.70-0.94) were independently associated with new-onset AF.

Abstract, Results, third sentence:

After further adjustment for lean mass, associations between fat mass (HR; 95% CI 1.17; 1.04-1.32), gynoid fat mass (HR; 95% CI 1.21; 1.08–1.37), and android-to-gynoid fat ratio (HR; 95% CI 0.84; 0.72–0.97) remained statistically significant.

Methods, Statistical analysis, which defines the model the abstract describes:

Model 2 was additionally adjusted for cardiovascular risk factors including total and HDL cholesterol, history of hypertension, history of diabetes mellitus (DM), history of coronary heart disease (CHD), history of heart failure (HF), history of left ventricular hypertrophy, smoking status, total alcohol intake, use of lipid-lowering medication, and use of cardiac medication. Moreover, we additionally adjusted for total lean mass in Model 3 and for total fat mass in Model 4, respectively.

Results, "Association of different fat depots with incident AF":

After adjustment for cardiovascular risk factors (model 2), higher levels of fat depots were significantly associated with new-onset AF with the exception for liver fat. The multivariable-adjusted HRs and 95% CIs were 1.22 (1.09–1.36) for fat mass, 1.14 (1.03–1.27) for android mass, 1.26 (1.13–1.41) for gynoid fat mass, and 1.27 (1.09–1.48) for epicardial fat. Notably, android-to-gynoid fat mass ratio showed an inverse association with incident AF [0.85 (0.74–0.98)].

Table 2 ("Associations between various DXA-based fat depots and incident atrial fibrillation", N = 3468), columns Model 1 | Model 2 | Model 3 | Model 4:

Total fat mass | 1.28 (1.15–1.42) | 1.22 (1.09–1.36) | 1.17 (1.04–1.32) | –
Gynoid fat mass | 1.31 (1.18–1.46) | 1.26 (1.13–1.41) | 1.21 (1.08–1.37) | 1.36 (0.96–1.93)
Android-to-gynoidfat ratio | 0.93 (0.81–1.06) | 0.85 (0.74–0.98) | 0.84 (0.72–0.97) | 0.82 (0.70–0.95)

Table 3 (CT-based), Model 2 column:

Epicardial fat | 1.31 (1.13–1.51) | 1.27 (1.09–1.48) | 1.16 (0.95–1.42) | 1.09 (0.87–1.38)

Additional file 1, Table S6, "Associations between various fat depots and incident atrial fibrillation, adjusting for body mass index and waist-to-hip ratio", columns Model 1 | Model 2 | Model 3 (text taken from the supplementary .docx; hyphens as printed there):

Total fat mass | 1.22 (1.09-1.36) | 1.33 (1.05-1.68) | 1.27 (1.13-1.42)
Gynoid fat mass | 1.26 (1.13-1.41) | 1.36 (1.12-1.65) | 1.29 (1.15-1.44)
Android-to-gynoid fat ratio | 0.85 (0.74-0.98) | 0.81 (0.70-0.94) | 0.77 (0.65-0.91)
Epicardial fat | 1.27 (1.09-1.48) | 1.18 (0.99-1.41) | 1.32 (1.11-1.57)

Table S6 footnote, excerpt:

Model 1 was adjusted for age, high-density lipoprotein cholesterol, total cholesterol, smoking, total alcohol intake, lipid lowering medication and cardiac medication, history of hypertension, left ventricular hypertrophy, diabetes mellitus, heart failure and coronary heart disease. Model 2: Model 1 + body mass index. Model 3: Model 1 + waist-to-hip ratio.

Discussion, "Study strengths and limitations", which cites Table S6:

Of note, findings indicated a robust and independent association between gynoid fat and android-to-gynoid fat ratio with AF after adjusting for BMI, WHR, or total lean mass, (Additional file 1: Table. S6)

What the paper's own numbers show

Method. I matched each hazard ratio (95% CI) in the abstract's "after adjustments for cardiovascular risk factors" sentence against every column of Tables 2 and 3 and of Supplementary Table S6. Assuming Wald intervals on the log scale, I took the implied standard error of each log hazard ratio as SE = [ln(upper) βˆ’ ln(lower)] / (2 Γ— 1.96). To make sure the differences are not a rounding effect, I also bounded each SE by moving the printed limits Β±0.005. Finally, as a rough benchmark, I compared each SE with the precision the event count allows: for a standardized exposure, SE β‰ˆ 1/√events. Every number below is printed by recompute.py.txt.

Quantity Location Reported Recomputed from the paper's own numbers
Total fat mass, adjusted for CV risk factors Abstract vs Table 2 Model 2 and Results 1.33 (1.05–1.68) vs 1.22 (1.09–1.36) Differ by +0.11 (+9.0%). Abstract equals Table S6 Model 2 (+BMI) exactly
Gynoid fat mass, adjusted for CV risk factors Abstract vs Table 2 Model 2 and Results 1.36 (1.12–1.65) vs 1.26 (1.13–1.41) Differ by +0.10 (+7.9%). Abstract equals Table S6 Model 2 (+BMI) exactly
Android-to-gynoid ratio, adjusted for CV risk factors Abstract vs Table 2 Model 2 and Results 0.81 (0.70–0.94) vs 0.85 (0.74–0.98) Differ by βˆ’0.04 (βˆ’4.7%). Abstract equals Table S6 Model 2 (+BMI) exactly
Epicardial fat, same abstract sentence Abstract vs Table 3 Model 2 1.27 (1.09–1.48) vs 1.27 (1.09–1.48) Identical. Table S6 Model 2 (+BMI) gives 1.18 (0.99–1.41), p β‰ˆ 0.067
Table S6 Model 1 vs Table 2/3 Model 2 Supplement vs main tables 1.22, 1.26, 0.85, 1.27 with the same CIs Identical for all four, so S6 Model 1 is the main-text Model 2
Implied SE of log HR, total fat Abstract vs Table 2 Model 2 β€” 0.120 vs 0.056. Ratio 2.12 (2.01–2.24 allowing for rounding)
Implied SE of log HR, gynoid fat Abstract vs Table 2 Model 2 β€” 0.099 vs 0.056. Ratio 1.75 (1.66–1.85)
Implied SE of log HR, A/G ratio Abstract vs Table 2 Model 2 β€” 0.075 vs 0.072. Ratio 1.05 (0.96–1.14)
Benchmark SE for 395 events Abstract and Results (395 AF cases, DXA) β€” 1/√395 = 0.050. Table 2 Model 2 SE 0.056 implies variance inflation of 1.26. Abstract SE 0.120 implies 5.68, which fits adding a covariate as collinear as BMI
Abstract values in any Table 2 column Table 2, Models 1–4 β€” No exact match. Only the gynoid point estimate 1.36 recurs, in Model 4, with CI 0.96–1.93
Lean-mass-adjusted values Abstract vs Table 2 Model 3 1.17 (1.04–1.32); 1.21 (1.08–1.37); 0.84 (0.72–0.97) Identical in both places

All three discordant abstract estimates reproduce the corresponding Table S6 Model 2 (+BMI) entries digit for digit. Their intervals are internally consistent: the geometric midpoints are 1.328, 1.359 and 0.811. Their widths are the ones expected after adding BMI, a covariate strongly correlated with total and gynoid fat. The SE for total fat roughly doubles, from 0.056 to 0.120, which no rounding of two-decimal limits can produce. The abstract sentence therefore reports three estimates from the BMI-adjusted model and one from the model without BMI, and describes all four with the wording that the Methods and Results use for Model 2.

Figure

Three of the four abstract estimates match the BMI-adjusted supplementary model rather than Table 2 Model 2

Figure 1. Three panels give the hazard ratios (95% CI) per 1 SD for the four fat measures in the abstract's "after adjustments for cardiovascular risk factors" sentence. Centre (orange): the abstract. Left (blue): Table 2/Table 3 Model 2 and the Results text, which the Methods define as the cardiovascular-risk-factor model. Right (dark grey): Supplementary Table S6 Model 2, which is that model plus body mass index. Each connector is labelled "same" (solid) or "differs" (dashed). For total fat mass, gynoid fat mass and the android-to-gynoid ratio, the abstract differs from Table 2 and equals Table S6 Model 2 exactly. For epicardial fat, the abstract equals Table 3 and differs from Table S6 Model 2.

The abstract's intervals coincide with the BMI-adjusted estimates and are wider than the Table 2 Model 2 intervals

Figure 2. The same estimates on one log-scale hazard-ratio axis, with a thin reference line at 1 (no association). Orange circles: abstract. Blue squares: Table 2/3 Model 2 (cardiovascular risk factors). Dark grey open diamonds: Table S6 Model 2 (cardiovascular risk factors + BMI). Each value is also printed at the right. For total and gynoid fat the abstract interval lies exactly on the BMI-adjusted one, and it is about twice as wide on the log scale as the Model 2 interval. For epicardial fat the abstract lies on Model 2, and the BMI-adjusted interval would cross 1. All estimates stay on the same side of 1 in every model except BMI-adjusted epicardial fat.

Why it matters

Explanations considered

Status

Suggested correction

In the abstract, either report the Model 2 estimates that the stated adjustment refers to:

After adjustments for cardiovascular risk factors, absolute fat mass (HR; 95% CI 1.22; 1.09–1.36), gynoid fat mass (HR; 95% CI 1.26; 1.13–1.41), epicardial fat mass (HR; 95% CI 1.27; 1.09–1.48), and android-to-gynoid fat ratio (HR; 95% CI 0.85; 0.74–0.98) were independently associated with new-onset AF.

or, if the BMI-adjusted estimates are intended, label them as such, for example "After adjustment for cardiovascular risk factors and body mass index, absolute fat mass (HR 1.33; 1.05–1.68), gynoid fat mass (HR 1.36; 1.12–1.65) and android-to-gynoid fat ratio (HR 0.81; 0.70–0.94) …". In that case the epicardial fat estimate from the same model, 1.18 (0.99–1.41), should replace 1.27 (1.09–1.48) or be reported separately. Nothing in Tables 2–4, the Results text or the supplement needs to change.